跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GEMTERO (GEMCITABINE HYDROCHLORIDE) FOR INJECTION 200MG/VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
GEMTERO (GEMCITABINE HYDROCHLORIDE) FOR INJECTION 200MG/VIAL
Approved
THERAPEUTIC
GEMTERO (GEMCITABINE HYDROCHLORIDE) FOR INJECTION 200MG/VIAL
HETERO LABS LIMITED (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Jun 12, 2014
Approval ID
7e1e92b8a2988eab
Company
HETERO LABS LIMITED (INDIA)
Type
Therapeutic
Approval Details
Approval Id
7e1e92b8a2988eab
Drug Name
GEMTERO (GEMCITABINE HYDROCHLORIDE) FOR INJECTION 200MG/VIAL
Product Name
GEMTERO (GEMCITABINE HYDROCHLORIDE) FOR INJECTION 200MG/VIAL
Approval Number
SIN14559P
Approval Date
2014-06-12
Registrant
MEDICELL PHARMACEUTICAL (S) PTE. LTD.
Licence Holder
MEDICELL PHARMACEUTICAL (S) PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
L01BC05
Atc Item Name
gemcitabine
Pharma Manufacturer Name
MEDICELL PHARMACEUTICAL (S) PTE. LTD.
Company Detail Path
/organization/medicell-pharmaceutical-s-pte-ltd
Active Ingredients
Gemcitabine Hydrochloride 227.6mg eqv Gemcitabine
200 mg
GEMCITABINE HYDROCHLORIDE 227.6 MG EQV GEMCITABINE
200 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 12, 2014
Approval ID
7e1e92b8a2988eab
Type
Therapeutic
Back to HSA Approvals
